Evotec: Important dates in the coming week:

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-an-mdax-spitze-das-ist-der-grund-20384104.html

Credibility C

Jul 30 25

Evotec: Share at the top of the MDAX - | this is the reason: Evotec plans to sell biologics site to Sandoz for $300 million to promote capital-light model.

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-bricht-massiv-ein-was-ist-da-los-20383542.html

Jul 21 25

Evotec: Share price collapses massively - | what's going on?: Evotec share price plummets after lowered sales forecast; EBITDA targets remain the same.

deraktionaer.de/artikel/aktien/evotec-aktie-wird-wieder-durchgereicht-20380889.html

May 27 25

Evotec: Shares are being passed on again: Evotec shares fall by 7%.

deraktionaer.de/artikel/pharma-biotech/evotec-mit-kurssprung-staerkster-wert-im-mdax-vor-traton-und-bilfinger-20380744.html

May 23 25

Evotec jumps share price - | strongest stock in the MDAX ahead of Traton and Bilfinger

deraktionaer.de/artikel/pharma-biotech/evotec-zwei-wichtige-termine--20371140.html

Dec 04 24

Evotec: Two important dates: Evotec could soon be promoted to the MDAX, while Befesa could be relegated to the SDAX and SMA Solar could be replaced by Ionos in ...

The San Diego Union-Tribune

A−

Nov 23 24

San Diego’s Halozyme withdraws $2.1B Evotec bid, just one week after making offer

sandiegouniontribune.com/2024/11/22/san-diegos-halozyme-withdraws-proposed-2-1b-acquisition-of-evotec/

Key FactsEvotec's MDAX Comeback on the Horizon

Nov 22, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de

Evotec may be poised for a return to the MDAX by the end of the year, as JPMorgan predicts the company's inclusion in the mid-cap index.

Halozyme Therapeutics has made a takeover offer for Evotec at 11 euros per share, valuing the company at around two billion euros.

Despite the stock briefly rising to 10.69 euros, it is currently hovering around the 10-euro mark, while Evotec aims to resist the takeover attempt.

For a successful deal, higher bids will be necessary, and Evotec must regain investor confidence to ensure long-term success.

6 similar articles

deraktionaer.de/artikel/pharma-biotech/evotec-extreme-ausschlaege-20370001.html

Nov 14 24

Evotec: Extreme Ausschläge: Evotec shares lose over 50% on an annual basis, but recover with 51.9% in a 1-month comparison as the SDAX leader.

Key FactsEvotec: Stock Shows Extreme Transformation

Nov 14, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: deraktionaer.de

Evotec's stock experienced a significant decline of over 50% last year but is now the top SDAX performer with a 51.9% monthly increase.

New CEO Christian Wojczewski announced progress on strategic initiatives aimed at long-term growth.

Speculation of a takeover arose as Triton acquired 9.16% of Evotec's voting rights, although the company denied any discussions.

Regaining investor confidence is crucial for Evotec, which needs to deliver important news in the coming months.

deraktionaer.de/artikel/aktien/evotec-vor-den-zahlen-die-spannung-steigt-geht-die-rally-weiter-20369405.html

Nov 05 24

Evotec before the figures: The tension is rising - | will the rally continue?: Evotec sells production facility, focuses on profitable growth and expects ...

deraktionaer.de/artikel/pharma-biotech/evotec-punktet-mit-novo-nordisk-kooperation-analyst-raet-zum-kauf-20367125.html

Sep 27 24

Evotec scores with Novo Nordisk cooperation - | Analyst recommends buying: Evotec shares rise after partnership with Novo Nordisk and positive analyst comment.

3 similar articles

deraktionaer.de/artikel/pharma-biotech/evotec-ceo-kauft-erneut-20366195.html

Sep 13 24

Evotec: CEO buys again: Evotec CEO buys shares, insider confidence rises ahead of MDAX relegation.

deraktionaer.de/artikel/aktien/evotec-zweimal-verkaufen-20364246.html

Aug 15 24

Evotec: "Sell" twice: Evotec shares stabilize after price slide near €6, analysts remain skeptical.

2 similar articles

BÖRSE ONLINE

Jul 10 24

MDAX leader thanks to Pfizer: Is the Evotec share finally turning up again on the stock market?

boerse-online.de/nachrichten/aktien/mdax-spitzenreiter-dank-pfizer-dreht-die-evotec-aktie-jetzt-an-der-boerse-endlich-wieder-auf-20361451.html

deraktionaer.de/artikel/technischeanalyse/evotec-wird-dieses-gap-tatsaechlich-noch-geschlossen-20359891.html

Jun 19 24

Evotec: Will this gap actually be closed?: Evotec shares fall to lowest level since 2017; Analyst recommends selling, sees risks and price target of 7.00 euros.

deraktionaer.de/artikel/pharma-biotech/evotec-nach-dem-horror-crash-wars-das-20356124.html

Apr 25 24

Evotec after the horror crash - was that it?: Evotec shares fall below 10 euros; new CEO and cost-cutting plan fail to reassure investors.

6 similar articles

deraktionaer.de/artikel/pharma-biotech/evotec-deutsche-bank-sagt-kaufen-aktie-top-gewinner-im-mdax-20355091.html

Apr 12 24

Evotec: Deutsche Bank says “Buy” - Share top winner in the MDAX: Evotec shares rise 7% after upgrade to “Buy” by Deutsche Bank with a price target of 19 euros.

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-massiv-angeschlagen-das-ist-jetzt-wichtig-20350558.html

Feb 15 24

Evotec: Shares massively hit - this is important now: Evotec shares weaken, -34% in 5 years. Technically uncertain on the chart, fundamental progress in ...

deraktionaer.de/artikel/pharma-biotech/evotec-aktie-erneut-im-plus-das-befuegelt-20348347.html

Jan 23 24

Evotec: Shares in positive territory again - that inspires: Evotec Stock Rebounds, Supported by Positive Conference Call and Analyst Praise; Short selling ...

3 similar articles

deraktionaer.de/artikel/pharma-biotech/evotec-talfahrt-gestoppt-das-befluegelt-die-aktie-20348016.html

Jan 18 24

Evotec: decline stopped - that boosts the share: Evotec shares are stabilizing after a sharp decline, helped by an upgrade from Bank RBC to Outperform ...

manager-magazin.de/unternehmen/pharma/evotec-aktienverkauf-kurz-vor-der-gewinnwarnung-a-9d57daae-68f6-4858-b90b-e89be1b8590c

Manager Magazin

Jan 12 24

Share sales: How the Evotec boss hid million-dollar deals for years: During his time on the board, Werner Lanthaler sold shares for six million euros before ...

Paid articlePaywall